Primary percutaneous coronary angioplasty for acute myocardial infarction at a rural area hospital - A great difference from the ideal

Acta Cardiologica Sinica

Volumn 23, Issue 4, 2007, Pages 225-233

  Chen, Chih Wei ^a   Lin, Chih Ta ^a   Lin, Tin Kwang ^a   Chen, Bin Chen ^a   Lin, Chin Lon ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute myocardial infarction; Primary percutaneous coronary angioplasty; Rural medicine

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENOXAPARIN; FIBRIC ACID DERIVATIVE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; TICLOPIDINE; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PATIENT INFORMATION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; REPERFUSION; RURAL AREA; ST SEGMENT ELEVATION; STENT; TREATMENT OUTCOME;

EID: 39149139373     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
2. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-73.
3. Gruppo Italiano per lo Studio della Streptochinasi nell'Infrato Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
4. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
5. Boersma E, Mass AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
6. Hartzier GO, Rutherford BD, McConahay DR, et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983;106:965-73.
7. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004;110:588-636.
8. Grines CL, Browne KR, Marco J, et al. A comparison of immdeiate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-91.
9. Zijlstra F, De Boer MJ, Hoorntje JC, et al. A comparison of immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
10. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndrome (GUSTO-IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-8.
11. Roe MT, Parsons LS, Pollack CV, et al. Quality of care by classification of myocardial infarction. Arch Intern Med 2005;165:1630-6.
12. rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit: A two year experience with 250 patients. Am J Cardiol 1967;20:457-64.
13. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006;355:2308-20.
14. Wang YC, Hwang JJ, Hung GS, et al. Outcome of primary percutaneous coronary intervention in octogenarians with acute myocardial infarction. J Formos Med Assoc 2006;105:451-8.
15. Lasky AJ, Pietras C, Costa RA, et al. Gender difference in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the controlled abciximab and device investigation to lower late angioplasty complications (CARDIALLAC) trial. Circulation 2005;111:1611-8.
16. Hillis LD, Forman S, Braunwald E and the Thrombolysis In Myocardial Infarction (TIMI) phase II co-investigators. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1990;16:313-5.
17. Ishihara M, Kojima S, Sakamoto T, et al. Usefulness of combined white blood cell count and plasma glucose for predicting in-hospital outcomes after acute myocardial infarction. Am J Cardiol 2006;97:1558-63.
18. Pimenta E, Ramos RF, Gun C, et al. Renal function outcome in acute myocardial infarction as a prognostic factor of in-hospital events and at one-year follow-up. Arg Bras Cardiol 2006;86:170-4.
19. Sakai K, Nakagawa Y, Kimura T, et al. Primary angioplasty of unprotected left main coronary artery for acute anterolateral myocardial infarction. J Invasive Cardiol 2004;16:621-5.
20. Gluppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gluppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet 1994;343:1115-22.
21. Fourth International Study of Infarct Survival (ISIS-4) Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenousmagnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
22. Wu AH, Parson L, Every NR, Bates ER, Second National Registry of Myocardial Infarction. Hospital outcomes in patients presenting with congestive heart failure: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2004;40:1389-94.